2021 Partners



Lead Partner

We share your passion for science. Promega is committed to excellence in technologies to assess key processes in PROTAC-induced protein degradation: compound binding and permeability, ternary complex formation, ubiquitination, and trafficking to proteasome. Assay live cells in kinetic mode to determine target protein degradation rates, DC50 potency values, and recovery profiles. Let’s collaborate.



Expertise Partner

CCG (Chemical Computing Group) is a leading supplier of software solutions for life sciences. With a proven track record in scientific innovation, CCG provides state-of-the-art applications in drug discovery to pharmaceutical, biotechnology and academic researchers. CCG headquarters are in Montreal (Canada), with support offices in North America, Europe and Asia.




Expertise Partner

Delve deeper into examining key targets involved in drug discovery, oncology, gene therapy and neurodegenerative disorders. Identify the critical molecules that influence targeted-protein degradation pathways with characterization tools from NanoTemper Technologies. We’re committed to enabling researchers to easily, efficiently, and precisely characterize proteins. With systems, software and consumables for evaluating and screening binding affinities, protein stability and protein quality, scientists in academia, biotech and pharmaceuticals will experience improved workflows and quality results.




Event Partner

BioTheryX, Inc., founded by the drug development team behind the remarkable IMiDs® franchise of compounds, is applying its extensive and proven commercial success to deliver efficacious therapies to patients with unmet medical needs focusing on orally available small molecules for the treatment of cancers and inflammatory diseases.  Our lead molecule targets Acute Myeloid Leukemia (in clinic Q2 2019) and our lead Protein Homeostatic Modulator (PHM™) will be in the clinic Q3 2020 for hematological malignancies.




Innovation Partner

At MilliporeSigma, our purpose is to solve the toughest problems in life science. To accelerate discovery for Targeted Protein Degradation, our Sigma-Aldrich Chemical Biology portfolio simplifies synthesis and library generation of protein degraders with degrader building blocks and custom synthesis capabilities. In addition to new degrader probes and lead discovery tools, TPD research is supported through our extensive offerings in bioactive small molecules, antibodies, western blotting, and genome editing tools such as CRISPR.


Nanome Logo


Innovation Partner

Nanome is changing how we understand, design, and interact with science. Nanome’s immersive virtual workspaces allow users to visualize, modify, and simulate chemical compounds, proteins, and nucleic acids to help improve the Drug Discovery process. Our virtual reality platform facilitates effective communication of structural data in drug discovery which has proved beneficial to several pharmaceutical and biotech companies across the globe. This is especially helpful for organizations that are interested in improving their cross-site collaboration.


Refeyn (002)


Innovation Partner

Refeyn pioneers mass photometry technology, producing a disruptive new generation of analytical instruments. The instruments quickly and simply measure the mass of individual molecules directly in solution without needing labels. Refeyn is transforming scientists’ abilities to characterise the function, structural composition and dynamics of biomolecules in near-native environments.



Proteome Sciences 

Exhibition Partner

We are a CRO specialising in the analysis of proteins and their associated PTM’s via advanced Mass Spectrometry.  By using proprietary methodologies, we can detect up to 8,000 proteins per sample in Discovery mode and can offer multiplexed assays of up to 100 proteins/sample in a GCLP accredited Targeted assay.

With their proprietary bioinformatics software, these can be trimmed down to some tens of proteins that are either up-, or down-regulated with disease progression or drug treatment.


Bio-Techne Logo


Exhibition Partner

Bio-Techne brings together some of the most referenced brands in life science to provide innovative tools for Targeted Protein Degradation. Boston Biochem are world leaders in ubiquitin-proteasome system-related products, Tocris Bioscience are market leaders for research tool Degraders and Degrader building blocks while ProteinSimple provide automated platforms for detecting and quantifying protein degradation via Western Blot. Together we are Bio-Techne. Find out how we can help you achieve your research goals.